Position in ABBV
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,686,474
-$1,550,617 QoQ
Shares Held
21,548
-21.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.64%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 83%
Shared 0%
None 17%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026S&T Bank/PA holds $5,949,719 across 10 Drug Manufacturers - General names. ABBV ranks #1 (78.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
21,548 | $4,686,474 | |
| 2 | JNJ |
Johnson & Johnson
|
2,263 | $553,167 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,564 | $188,133 | |
| 4 | LLY |
ELI LILLY & Co
|
200 | $183,953 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,916 | $116,204 | |
| 6 | AMGN |
Amgen Inc
|
299 | $105,202 | |
| 7 | NVO |
Novo Nordisk A S
|
1,430 | $52,552 | |
| 8 | PFE |
Pfizer Inc
|
1,314 | $36,896 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,686,474 | 21,548 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,237,091 | 27,297 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $7,730,425 | 33,387 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $7,000,101 | 37,712 | Shares | Defined | 2025-08-06 | |
| 2025-03-31 | $8,585,290 | 40,976 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,416,664 | 41,737 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,342,976 | 47,311 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $9,734,103 | 56,752 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,959,510 | 71,167 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,742,252 | 82,224 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $12,756,852 | 85,582 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,928,454 | 88,536 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $15,071,620 | 94,570 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $16,243,743 | 100,512 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,627,549 | 101,539 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $15,965,398 | 104,240 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $18,401,429 | 113,512 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,877,951 | 117,267 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $12,495,876 | 115,842 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $12,124,118 | 107,636 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $11,162,784 | 103,149 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $11,323,396 | 105,678 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $9,711,014 | 110,869 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,858,769 | 120,786 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $9,204,055 | 120,804 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||